申请人:RIGEL PHARMACEUTICALS INC
公开号:WO2014043257A1
公开(公告)日:2014-03-20
Compounds I and II, as well as prodrugs, hydrates, solvates, N-oxides, salts and pharmaceutical compositions containing them, are useful for treating vitiligo. In certain embodiments, the compounds are provided in topical compositions. (The chemical formulas should be inserted here.)